Facilitated By

San Antonio Medical Foundation

News

  • Myriad study shows breast cancer recurrence test can predict therapy responses

    The studies were presented at the San Antonio Breast Cancer Symposium. A retrospective analysis of five prospective studies evaluated 3,746 ...

  • Moderna is sliding in its Wall Street debut after the biggest IPO in biotech history (MRNA, TBIO)

    Moderna Therapeutics just started trading, after the biggest initial public offering in biotech history. The stock slid 5.7 percent to $21.65 in its trading ...

  • Bb Biotech Ag Has Trimmed Its Regeneron Pharmaceuticals (REGN) Position; Oberweis Asset ...

    Bb Biotech Ag decreased Regeneron Pharmaceuticals Inc. (REGN) stake by ... Bb Biotech Ag sold 10,000 shares as Regeneron Pharmaceuticals Inc. .... Energy for project at Joint Base San Antonio – Seeking Alpha” published on ...

  • Puma Biotech (PBYI) Highlights Updated Data from Patient Reported Outcomes in Phase II ...

    Puma Biotechnology, Inc. (NASDAQ: PBYI) is presenting updated results from a Phase II clinical trial of Puma's drug neratinib at the 2018 San Antonio ...

  • Puma Biotech (PBYI) Announces Results from Phase II SUMMIT Trial of Neratinib for ERBB2 ...

    Puma Biotech (PBYI) Announces Results from Phase II SUMMIT Trial of ... Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, ... at the 2018 San Antonio Breast Cancer Symposium (SABCS) that is currently ...